AVOI yields 307.69% · PFE yields 6.13%● Live data
📍 AVOI pulled ahead of the other in Year 1
Combined, AVOI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AVOI + PFE for your $10,000?
Advanced Voice Recognition Systems, Inc., a software development company, specializes in creating interface and application solutions for speech recognition technologies in the United States. Its principal proposed product or service includes speech recognition software and related firmware, which allows for dictation into a range of applications comprising DOS applications running in Windows; UNIX and mainframe applications accessed through terminal emulation programs; various custom applications; and Windows 3.x, 95, 98, 2000, XP, Vista, Windows 7, and Windows 10 programs. The company also focuses on offering AVRS Enterprise solutions that are applicable to various primary stream speech enabled applications, such as traditional desktop applications, as well as mobile and web-based, and cloud solutions. It focuses on serving corporations, hospitals, medical product and service providers, governmental entities, legal professionals, sales and service organizations, law enforcement agencies, and mobile search and voicemail to text markets that require individuals and organizations to create reports, letters, email, data entry, manuals, books, and other documents or end products involving written data. The company was founded in 1994 and is headquartered in Scottsdale, Arizona.
Full AVOI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.